ScienceDex / Researcher record
Allen, Joshua E.
- Oncoceutics, Inc. (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2019
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2019): $1.8M in linked award amounts across 2 award records · Award-linked rank #3755.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2019 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Citation measures
From OpenAlex data as of September 23, 2026. Google Scholar and Scopus count other sources, so their numbers differ.
Each number opens a page that explains the measure and compares researchers on it.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award records by amount
NIH award records listing Allen, Joshua E. as a PI. Multi-PI records show the full award amount for context.
- 5R44CA192427-05R44Contact PIAdaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma$999.6Kaward amount
- 5R44CA221398-03R44Contact PIClinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer$777Kaward amount
Award organization
Organizations that administered FY2019 awards listing Allen, Joshua E. as a PI.
FY2019 award administered by Oncoceutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardOncoceutics, Inc.
- 2019$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #3755
- 2019Entered Top 25% NationallyRanked #3755